Better blood type testing for high-risk pregnancies
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This study tests a new, more detailed blood test to figure out your baby's blood type during pregnancy. This may help doctors better manage pregnancies affected by blood-type incompatibility and prevent hemolytic disease in newborns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and your blood has antibodies that attack your baby's red blood cells, a condition called red blood cell alloimmunization.
- You are not currently having a miscarriage or terminating the pregnancy for reasons other than this blood condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks pregnancies affected by hemolytic disease of the fetus and newborn (HDFN). It collects information to better understand the condition and improve care. You may join if you are pregnant with a history of a prior affected pregnancy and have a current antibody that could harm your baby.
This study is looking at a new way to detect bleeding between the mother and baby during pregnancy (called fetomaternal hemorrhage), which can lead to a blood problem in the newborn called hemolytic disease. The goal is to see if this test can help diagnose the condition earlier and hopefully improve care for the baby.
This study tests a new blood test that can screen for genetic problems in babies during pregnancy. It may find more conditions than standard tests, especially for pregnancies with certain ultrasound findings or other risk factors.
This study tests a safer blood test to check for certain genetic disorders during pregnancy, instead of an invasive procedure like amniocentesis. It's for pregnant women who are at risk of passing on a known genetic condition.
This study tests a new blood test that looks for fetal cells in your bloodstream to check your baby's health during pregnancy. The test is non-invasive—just a regular blood draw—and aims to help identify pregnancy risks earlier than traditional methods.
This study looks at a blood test done early in pregnancy (NIPT) to see if it can help predict conditions like preeclampsia, preterm labor, or gestational diabetes. If you had this test and had a healthy pregnancy or one of these complications, you may be able to join.
Hear when a new Next Generation Sequencing (NGS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.